8 research outputs found

    PKCĪ¶ Mediates Breakdown of Outer Blood-Retinal Barriers in Diabetic Retinopathy.

    Get PDF
    AIMS/HYPOTHESIS: Diabetic macular edema represents the main cause of visual loss in diabetic retinopathy. Besides inner blood retinal barrier breakdown, the role of the outer blood retinal barrier breakdown has been poorly analyzed. We characterized the structural and molecular alterations of the outer blood retinal barrier during the time course of diabetes, focusing on PKCĪ¶, a critical protein for tight junction assembly, known to be overactivated by hyperglycemia. METHODS: Studies were conducted on a type2 diabetes Goto-Kakizaki rat model. PKCĪ¶ level and subcellular localization were assessed by immunoblotting and immunohistochemistry. Cell death was detected by TUNEL assays. PKCĪ¶ level on specific layers was assessed by laser microdissection followed by Western blotting. The functional role of PKCĪ¶ was then evaluated in vivo, using intraocular administration of its specific inhibitor. RESULTS: PKCĪ¶ was localized in tight junction protein complexes of the retinal pigment epithelium and in photoreceptors inner segments. Strikingly, in outer segment PKCĪ¶ staining was restricted to cone photoreceptors. Short-term hyperglycemia induced activation and delocalization of PKCĪ¶ from both retinal pigment epithelium junctions and cone outer segment. Outer blood retinal barrier disruption and photoreceptor cone degeneration characterized long-term hyperglycemia. In vivo, reduction of PKCĪ¶ overactivation using a specific inhibitor, restored its tight-junction localization and not only improved the outer blood retinal barrier, but also reduced photoreceptor cell-death. CONCLUSIONS: In the retina, hyperglycemia induced overactivation of PKCĪ¶ is associated with outer blood retinal barrier breakdown and photoreceptor degeneration. In vivo, short-term inhibition of PKCĪ¶ restores the outer barrier structure and reduces photoreceptor cell death, identifying PKCĪ¶ as a potential target for early and underestimated diabetes-induced retinal pathology

    Therapeutic Human Papillomavirus Vaccines

    No full text
    corecore